NewsDialy
An effort to link technology with medicine is taking shape in China. Huawei is seeking to expand its artificial intelligence partnerships within the country's pharmaceutical sector.
Artificial intelligence, meaning software that analyzes data and draws conclusions in ways that typically require human judgment, is what the company wants to bring to the space.
The pharmaceutical sector is, in plain terms, the industry that researches, develops, and sells medicines. Huawei is actively pursuing more of these relationships there.
What has not been specified is which pharmaceutical companies may be involved and what form the partnerships might take. No financial terms or named partners have been reported.
Keep reading